Role of MC1R variants in uveal melanoma
2003

MC1R Variants and Uveal Melanoma Risk

Sample size: 350 publication 10 minutes Evidence: moderate

Author Information

Author(s): Neil Hearle, James Humphreys, Brian E. Damato, Richard Wort, Radu Talaban, James Wixey, Hannah Green, Douglas F. Easton, Richard S. Houlston

Primary Institution: Haddow Laboratories, Section of Cancer Genetics, Institute of Cancer Research

Hypothesis

Do germline MC1R variants increase the risk of uveal melanoma?

Conclusion

MC1R variants are unlikely to confer an increased risk of uveal melanoma.

Supporting Evidence

  • MC1R variants were detected in patients with uveal melanoma.
  • The frequency of MC1R variants in patients was similar to that in the general population.
  • Age at diagnosis was not significantly different between carriers and noncarriers of MC1R variants.
  • Previous studies also found no relationship between MC1R variants and uveal melanoma risk.

Takeaway

This study looked at whether certain gene changes make people more likely to get a rare eye cancer. It found that these gene changes don't seem to increase the risk.

Methodology

The study analyzed genetic variants in 350 patients with uveal melanoma and compared them to 133 controls.

Limitations

The study may not have been powered to detect very small increases in risk.

Participant Demographics

350 unrelated patients with uveal melanoma, 183 males (52%), average age 58 years.

Statistical Information

P-Value

0.05

Confidence Interval

0.68–1.56

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6601358

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication